Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2

Abstract

References 52

1. 1.

   Chasis H, Jolliffe N, Smith HW. The action of phlorizin on the excretion of glucose, xylose, sucrose, creatinine and urea by man. J Clin Invest. 1933;12:1083-1090.

   Not in our library10.1172/jci100559 (opens in a new tab)

2. 2.

   Burg MB, Knepper MA. Single tubule perfusion techniques. Kidney Int. 1986;30:166-170.

   Not in our library10.1038/ki.1986.168 (opens in a new tab)

3. 3.

   Barfuss DW, Schafer JA. Differences in active and passive glucose transport along the proximal nephron. Am J Phys. 1981;241:F322-F332.

   Not in our library10.1152/ajprenal.1981.241.3.f322 (opens in a new tab)

4. 4.

   Schultz SG, Curran PF. Coupled transport of sodium and organic solutes. Physiol Rev. 1970;50:637-718.

   Not in our library10.1152/physrev.1970.50.4.637 (opens in a new tab)

5. 5.

   Hopfer U, Nelson K, Perrotto J, Isselbacher KJ. Glucose transport in isolated brush border membrane from rat small intestine. J Biol Chem. 1973;248:25-32.

   Not in our library

6. 6.

   Wright EM, Loo DD, Hirayama BA. Biology of human sodium glucose transporters. Physiol Rev. 2011;91:733-794.

   Not in our library10.1152/physrev.00055.2009 (opens in a new tab)

7. 7.

   Fanconi G, Bickel H. Chronic aminoaciduria (amino acid diabetes or nephrotic-glucosuric dwarfism) in glycogen storage and cystine disease. Helv Paediatr Acta. 1949;4:359-396.

   Not in our library

8. 8.

   Santer R, Schneppenheim R, Dombrowski A, Gotze H, Steinmann B, Schaub J. Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat Genet. 1997;17:324-326.

   Not in our library10.1038/ng1197-324 (opens in a new tab)

9. 9.

   Santer R, Groth S, Kinner M, et al. The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome. Hum Genet. 2002;110:21-29.

   Not in our library10.1007/s00439-001-0638-6 (opens in a new tab)

10. 10.

    Mudaliar S, Polidori D, Zambrowicz B, Henry RR. Sodium-glucose cotransporter inhibitors: effects on renal and intestinal glucose transport: from bench to bedside. Diabetes Care. 2015;38:2344-2353.

    Not in our library10.2337/dc15-0642 (opens in a new tab)

11. 11.

    Gallo LA, Wright EM, Vallon V. Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences. Diab Vasc Dis Res. 2015;12:78-89.

    Not in our library10.1177/1479164114561992 (opens in a new tab)

12. 12.

    Hediger MA, Coady MJ, Ikeda TS, Wright EM. Expression cloning and cDNA sequencing of the Na+/glucose co-transporter. Nature. 1987;330:379-381.

    Not in our library10.1038/330379a0 (opens in a new tab)

13. 13.

    Hediger MA, Turk E, Wright EM. Homology of the human intestinal Na+/glucose and Escherichia coli Na+/proline cotransporters. Proc Natl Acad Sci U S A. 1989;86:5748-5752.

    Not in our library10.1073/pnas.86.15.5748 (opens in a new tab)

14. 14.

    Wells RG, Pajor AM, Kanai Y, Turk E, Wright EM, Hediger MA. Cloning of a human kidney cDNA with similarity to the sodium-glucose cotransporter. Am J Phys. 1992;263:F459-F465.

    Not in our library10.1152/ajprenal.1992.263.3.f459 (opens in a new tab)

15. 15.

    Wright EM, Turk E. The sodium/glucose cotransport family SLC5. Pflugers Arch. 2004;447:510-518.

    Not in our library10.1007/s00424-003-1202-0 (opens in a new tab)

16. 16.

    Wright EM. Glucose transport families SLC5 and SLC50. Mol Asp Med. 2013;34:183-196.

    Not in our library10.1016/j.mam.2012.11.002 (opens in a new tab)

17. 17.

    Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab Pharmacokinet. 2005;20:452-477.

    Not in our library10.2133/dmpk.20.452 (opens in a new tab)

18. 18.

    Park J, Shrestha R, Qiu C et al (2018) Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science 360:758–763

    Not in our library10.1126/science.aar2131 (opens in a new tab)

19. 19.

    Faham S, Watanabe A, Besserer GM, et al. The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na+/sugar symport. Science. 2008;321:810-814.

    Not in our library10.1126/science.1160406 (opens in a new tab)

20. 20.

    Watanabe A, Choe S, Chaptal V, et al. The mechanism of sodium and substrate release from the binding pocket of vSGLT. Nature. 2010;468:988-991.

    Not in our library10.1038/nature09580 (opens in a new tab)

21. 21.

    Cramer SC, Pardridge WM, Hirayama BA, Wright EM. Colocalization of GLUT2 glucose transporter, sodium/glucose cotransporter, and gamma-glutamyl transpeptidase in rat kidney with double-peroxidase immunocytochemistry. Diabetes. 1992;41:766-770.

    Not in our library10.2337/diab.41.6.766 (opens in a new tab)

22. 22.

    Balen D, Ljubojevic M, Breljak D, et al. Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody. Am J Phys Cell Phys. 2008;295:C475-C489.

    Not in our library10.1152/ajpcell.00180.2008 (opens in a new tab)

23. 23.

    Sabolic I, Vrhovac I, Eror DB, et al. Expression of Na+−D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences. Am J Phys Cell Phys. 2012;302:C1174-C1188.

    Not in our library10.1152/ajpcell.00450.2011 (opens in a new tab)

24. 24.

    Vrhovac I, Balen Eror D, Klessen D, et al. Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart. Pflugers Arch. 2015;467:1881-1898.

    Not in our library10.1007/s00424-014-1619-7 (opens in a new tab)

25. 25.

    Scafoglio C, Hirayama BA, Kepe V, et al. Functional expression of sodium-glucose transporters in cancer. Proc Natl Acad Sci U S A. 2015;112:E4111-E4119.

    Not in our library10.1073/pnas.1511698112 (opens in a new tab)

26. 26.

    Hummel CS, Lu C, Loo DD, Hirayama BA, Voss AA, Wright EM. Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2. Am J Phys Cell Phys. 2011;300:C14-C21.

    Not in our library10.1152/ajpcell.00388.2010 (opens in a new tab)

27. 27.

    Sala-Rabanal M, Hirayama BA, Ghezzi C, et al. Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice. J Physiol. 2016;594:4425-4438.

    Not in our library10.1113/jp271904 (opens in a new tab)

28. 28.

    Powell DR, DaCosta CM, Gay J, et al. Improved glycemic control in mice lacking Sglt1 and Sglt2. Am J Physiol Endocrinol Metab. 2013;304:E117-E130.

    Not in our library10.1152/ajpendo.00439.2012 (opens in a new tab)

29. 29.

    Santer R, Kinner M, Lassen CL, et al. Molecular analysis of the SGLT2 gene in patients with renal glucosuria. J Am Soc Nephrol. 2003;14:2873-2882.

    Not in our library10.1097/01.asn.0000092790.89332.d2 (opens in a new tab)

30. 30.

    Wright E, Lifton R, Somlo S, Giebisch GH, Seldin DW. Diseases of renal glucose handling. Genetic diseases of the kidney. 2009;131-140.

    Not in our library

31. 31.

    Ghezzi C, Hirayama BA, Gorraitz E, Loo DD, Liang Y, Wright EM. SGLT2 inhibitors act from the extracellular surface of the cell membrane. Phys Rep. 2014;2:e12058.

    Not in our library10.14814/phy2.12058 (opens in a new tab)

32. 32.

    Ghezzi C, Yu AS, Hirayama BA, et al. Dapagliflozin binds specifically to sodium-glucose cotransporter 2 in the proximal renal tubule. J Am Soc Nephrol. 2017;28:802-810.

    Not in our library10.1681/asn.2016050510 (opens in a new tab)

33. 33.

    Hummel C, Lu C, Liu J, et al. Structural selectivity of human SGLT inhibitors. Am J Phys Cell Phys. 2012;302:C373-C382.

    Not in our library10.1152/ajpcell.00328.2011 (opens in a new tab)

34. 34.

    Silverman M. The in vivo localization of high-affinity phlorizin receptors to the brush border surface of the proximal tubule in dog kidney. Biochim Biophys Acta. 1974;339:92-102.

    Not in our library10.1016/0005-2736(74)90335-6 (opens in a new tab)

35. 35.

    Abramson J, Wright EM. Structure and function of Na(+)-symporters with inverted repeats. Curr Opin Struct Biol. 2009;19:425-432.

    Not in our library10.1016/j.sbi.2009.06.002 (opens in a new tab)

36. 36.

    Yan N. Structural biology of the major facilitator superfamily transporters. Annu Rev Biophys. 2015;44:257-283.

    Not in our library10.1146/annurev-biophys-060414-033901 (opens in a new tab)

37. 37.

    Loo DD, Jiang X, Gorraitz E, Hirayama BA, Wright EM. Functional identification and characterization of sodium binding sites in Na symporters. Proc Natl Acad Sci U S A. 2013;110:E4557-E4566.

    Not in our library10.1073/pnas.1319218110 (opens in a new tab)

38. 38.

    Adelman JL, Ghezzi C, Bisignano P, et al. Stochastic steps in secondary active sugar transport. Proc Natl Acad Sci U S A. 2016;113:E3960-E3966.

    Not in our library10.1073/pnas.1525378113 (opens in a new tab)

39. 39.

    Kanai Y, Lee WS, You G, Brown D, Hediger MA. The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest. 1994;93:397-404.

    Not in our library10.1172/jci116972 (opens in a new tab)

40. 40.

    Pajor AM, Randolph KM, Kerner SA, Smith CD. Inhibitor binding in the human renal low- and high-affinity Na+/glucose cotransporters. J Pharmacol Exp Ther. 2008;324:985-991.

    Not in our library10.1124/jpet.107.129825 (opens in a new tab)

Cited by papers we hold 7

• Phlorizin alleviates mastitis and preserves the blood-milk barrier by metabolizing into phloretin · 2025
  Not checked
• Efficacy and Safety of Dapagliflozin in Children With Inherited Proteinuric Kidney Disease: A Pilot Study · 2022
  Not checked
• Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease · 2022
  No notice
• An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors · 2022
  No notice
• Sodium-Glucose Cotransporter 2 Inhibitors Mechanisms of Action: A Review · 2021
  No notice
• Single cell transcriptional and chromatin accessibility profiling redefine cellular heterogeneity in the adult human kidney · 2021
  No notice
• SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects · 2019
  No notice

Questions about this paper

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.